These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9391693)

  • 1. Muromonab-CD3 and antithymocyte globulin in renal transplantation.
    Burk ML; Matuszewski KA
    Ann Pharmacother; 1997 Nov; 31(11):1370-7. PubMed ID: 9391693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
    Hill P; Cross NB; Barnett AN; Palmer SC; Webster AC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004759. PubMed ID: 28073178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster AC; Wu S; Tallapragada K; Park MY; Chapman JR; Carr SJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004756. PubMed ID: 28731207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
    Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
    Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody induction therapy for lung transplant recipients.
    Penninga L; Møller CH; Penninga EI; Iversen M; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD008927. PubMed ID: 24282128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
    Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
    Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory acute renal allograft rejection successfully treated with photopheresis.
    Genberg H; Kumlien G; Shanwell A; Tydén G
    Transplant Proc; 2005 Oct; 37(8):3288-9. PubMed ID: 16298575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T; Papapostolou G; Schenker P; Kapischke M
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies in renal transplantation: a review.
    Parlevliet KJ; Schellekens PT
    Transpl Int; 1992 Sep; 5(4):234-46. PubMed ID: 1418316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.
    Webster A; Pankhurst T; Rinaldi F; Chapman JR; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004756. PubMed ID: 16625610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two approaches to comparing hospital charges between cadaveric renal transplant patients who received orthoclone OKT 3 sterile solution or Atgam sterile solution for induction therapy.
    Schommer JC; Pleil AM; Pathak DS
    Clin Ther; 1995; 17(4):749-69; discussion 748. PubMed ID: 8565038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of heart transplant rejection with either antithymocyte globulin-, Minnesota antilymphocyte globulin-, or an OKT3-based protocol.
    Ladowski JS; Dillon T; Schatzlein MH; Peterson AC; Deschner WP; Beatty L; Sullivan M; Scheeringa RH; Clark WR
    J Cardiovasc Surg (Torino); 1993 Apr; 34(2):135-40. PubMed ID: 8320247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody induction therapy in renal transplant patients receiving calcineurin-inhibitor immunosuppressive regimens: a comparative review.
    Nashan B
    BioDrugs; 2005; 19(1):39-46. PubMed ID: 15691216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cost-effectiveness Analysis of Rabbit Antithymocyte Globulin Versus Antithymocyte Globulin-fresenius as Induction Therapy for Patients With Kidney Transplantation From Donation After Cardiac Death in China.
    Xuan D; Chen G; Wang C; Yao X; Yin H; Zhang L; Xuan J; Chen L
    Clin Ther; 2018 Oct; 40(10):1741-1751. PubMed ID: 30243768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of OKT3 in cadaveric renal transplantation for rejection that is unresponsive to conventional anti-rejection therapy.
    Norman DJ; Barry JM; Bennett WM; Leone M; Henell K; Funnell B; Hubert B
    Am J Kidney Dis; 1988 Feb; 11(2):90-3. PubMed ID: 3124611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.
    Heifets M; Saeed MI; Parikh MH; Sierka D; Kumar MS
    Drugs Aging; 2004; 21(11):747-56. PubMed ID: 15323580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era.
    Hariharan S; Alexander JW; Schroeder TJ; First MR
    Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate and long-term results of ATG induction therapy for delayed graft function compared to conventional therapy for immediate graft function.
    Lange H; Müller TF; Ebel H; Kuhlmann U; Grebe SO; Heymanns J; Feiber H; Riedmiller H
    Transpl Int; 1999; 12(1):2-9. PubMed ID: 10080400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.